Karin Tyburski

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS4
- INTERVENTIONS2
- SINCE2009

Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
November 2009 - October 2014
Breast Neoplasms
Ovarian Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Cediranib
Olaparib



